Feb 14 (Reuters) - Australian shares climbed on Tuesday, lifted by hopes around U.S. inflation data due later in the day, which could influence the Federal Reserve's monetary policy path.
The S&P/ASX 200 index (xjo) rose 0.7% to 7,466.9 by 2341 GMT, amid gains across all sectors. The benchmark had declined 0.2% on Monday.
January's U.S. inflation data could indicate how well the Fed's monetary tightening policy has performed and whether its future rate-hike trajectory would change from hereon.
Domestic technology stocks .AXIJ were the top gainers, tracking their overseas peers and jumping 1.4%.
ASX-listed shares of Block Inc (SQ2) and Xero Ltd (XRO) climbed 2.7% and 1.7%, respectively.
Firmer oil prices further boosted the benchmark, with energy stocks .AXEJ rising 1%. Sector heavyweights Woodside Energy Group (WDS) and Santos (STO) added 1.5% and 1.1%, respectively.
Export-reliant miners .AXMM gained 0.3%. BHP Group (BHP) , Rio Tinto (RIO) , and Fortescue Metals Group (FMG) rose between 0.2% and 0.6%.
Financials .AXFJ added 0.9%, with all "Big Four" posting gains.
Among individual stocks, the world's largest fibre cement maker James Hardie (JHX) fell up to 8.7% after lowering its annual earnings guidance for the third time on account of weaker demand from its North America and Asia-Pacific geographies.
Biotech giant CSL Ltd (CSL) rose as much as 1%. It posted a 10% jump in its first-half profit, surpassing estimates, on account of higher blood plasma collections and the acquisition of Swiss drugmaker Vifor Pharma AG boosting its bottomline.
In New Zealand, the benchmark S&P/NZX 50 index (nz50) rose 0.3% to 12,108.61.
- Forums
- ASX - By Stock
- News: XIJ Australian shares see broad gains, U.S. inflation data in focus
Feb 14 (Reuters) - Australian shares climbed on Tuesday, lifted...
Featured News
Add XIJ (ASX) to my watchlist
|
|||||
Last
2,379.6 |
Change
3.400(0.14%) |
Mkt cap ! n/a |
Open | High | Low |
2,376.2 | 2,379.6 | 2,370.7 |
Featured News
XIJ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online